Clinical Trial Update: Genomic Responses of Human Immune and Non-Immune Cells to Glucocorticoids [Phase 1]

View source ↗

Summary

Phase 1 study evaluating genomic responses of human immune and non-immune cells to glucocorticoids; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Normal Physiology

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Normal Physiology | Phase 1 | Status: COMPLETED | Results posted: 2023-06-22